Skip to search formSkip to main contentSkip to account menu

docarpamine

Known as: N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine, do carpamine 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

DopamineDopamine Agonists

Narrower (1)

TA-8704
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Effects of a new orally active dopamine prodrug, docarpamine, on refractory ascites: a pilot study
OBJECTIVE:Refractory ascites is a debilitating condition in patients with cirrhosis. Recently, docarpamine, an orally active… 
1997
1997
EFFECT OF DOCARPAMINE,A NOVEL ORALLY ACTIVE DOPAMINE PRODRUG,ON THE FORMATION OF FREE AND SULFOCONJUGATED DOPAMINE IN PATIENTS WHO UNDERWENT CARDIAC SURGERY…
1995
1995
経口ドパミンプロドラッグ : ドカルパミン docarpamine
1995
1995
生理食塩液負荷麻酔犬の心および腎機能に対する経口 Dopamine prodrug, Docarpamine と強心薬 Denopamine の単独および併用効果
1991
1991
EFFECTS OF DOCARPAMINE (TA-870), AN ORALLY EFFECTIVE DOPAMINE PRODRUG, ON PERIPHERAL BLOOD FLOW IN ANESTHETIZED DOGS
1991
1991
GENERAL PHARMACOLOGY OF DOCARPAMINE (TA-870) A NOVEL ORALLY ACTIVE DOPAMINE PRODRUG. I, EFFECTS ON THE CENTRAL NERVOUS SYSTEM
1991
1991
塩酸ドパミン点滴中の循環不全患者に対する新規経口ドパミン薬 docarpamine (TA-870) の薬効評価
1991
1991
GENERAL PHARMACOLOGY OF DOCARPAMINE (TA-870), A NOVEL ORALLY ACTIVE DOPAMINE PRODRUG. II, EFFECTS OF PERIPHERAL ORGANS
1991
1991
循環不全に対する経口 dopamine プロドラック (docarpamine) の臨床的検討